Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic evidence for single bacteria cause of sepsis identified for the first time

21.03.2014

University of Leicester academic involved in study into single bacteria causes of systematic disease

An international team of academics, including Professor Marco Oggioni from the University of Leicester's Department of Genetics, has studied how localised infections can turn into the dangerous systematic disease sepsis – and has identified for the first time through genetic evidence that a single bacteria could be the cause.


Rather than from a mixture of cooperating bacteria, sepsis seems to originate from a single bacterial cell.

Credit: Image credit: Marco R. Oggioni

The study, which has been published in the academic journal PLOS Pathogens, examined the events that lead to sepsis by Streptococcus pneumoniae (pneumococcus), a major human pathogen, in mice. They found that in most cases the bacteria causing sepsis was started by a single pneumococcal cell.

The study was an interdisciplinary collaboration between the Departments of Genetics, Infection Immunity and Inflammation and Mathematics at the University of Leicester, Professor Richard Moxon at the University of Oxford and scientists from overseas including the University of Siena.

... more about:
»Genetic »bacteria »immune »injected »macrophages »systemic

Professor Oggioni said: "Our data in experimental infection models indicate that we do not need only strategies which target many bacteria when it is too late, but that early intervention schemes which prevent the one-single cell that starts the disease process might provide substantial benefit to the patient.

"In this work we have for the first time provided genetic evidence for a single cell origin of bacterial invasive infection. The scenario was hypothesised over 50 years ago, but so far only phenotypic and statistical evidence could be obtained for this event."

Under normal circumstances, when different bacteria are used in models of experimental infection of hosts who have not previously encountered the same pathogen, the vast majority is destroyed rapidly by the host's innate immune system.

In the researcher's model, a dose of one million bacteria is needed to induce systemic disease in about half of the hosts in the study.

This is in stark contrast to a much lower number of bacteria thought to make up the starting "seed" that leads to the development of systemic infection - and the assumption is that there must be one or more "bottlenecks" in the development of the disease.

To investigate these bottlenecks, the researchers injected mice with a mix of three different variants of S. pneumoniae. About half of the mice developed sepsis and in almost all cases the bacteria causing sepsis were derived from only one of the three variants used in the initial challenge.

Using statistical analysis as well as direct DNA sequencing, the researchers could show that in most cases the bacterial population causing sepsis was started by a single pneumococcal cell.

When the researchers looked closer at how the immune system resists most injected bacteria, they found that macrophages, a type of immune cell that can gobble up bacteria, and specifically macrophages in the spleen, are the main contributors to an efficient immune response to this pathogen.

Their findings suggest that if bacteria survive this initial counter-attack, a single 'founder' bacterium multiplies and re-enters the bloodstream, where its descendants come under strong selective pressure that dynamically shapes the subsequent bacterial population – resulting in the sepsis.

The data also suggests that the single bacterium leading to sepsis has no obvious characteristics that give it an advantage over the 999,999 others, but that random events determine which of the injected bacteria survives and multiplies to cause disease.

It is believed that the findings, suggesting that the development of sepsis starting from a single founding cell which survives the immune system's initial counter-attack in mice, could also potentially apply to human systemic infections.

This information could prove vital to understanding sepsis, as the causes of the disease are still largely unknown to the scientific community.

Dr Oggioni added: "Knowing that there is a moment when a single bacterial cell escapes "normal" immune surveillance at the beginning of each invasive infection is an important paradigm and essential information which, in our opinion, should lead to changes in therapeutic protocols in order to maximise success of treatment outcome."

###

The study, 'The Role of Host and Microbial Factors in the Pathogenesis of Pneumococcal Bacteraemia Arising from a Single Bacterial Cell Bottleneck', has been published in the academic journal PLOS Pathogens on Thursday 20 March.

Marco Oggioni | EurekAlert!

Further reports about: Genetic bacteria immune injected macrophages systemic

More articles from Life Sciences:

nachricht Breaking through a double wall with a sledgehammer
29.06.2015 | Max-Planck-Institut für Entwicklungsbiologie

nachricht Lean but sated: Molecular Switch for a Healthy Metabolism discovered
29.06.2015 | Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

Im Focus: Lasers for Fast Internet in Space – Space Technology from Aachen

On June 23, the second Sentinel mission was launched from the space mission launch center in Kourou. A critical component of Aachen is on board. Researchers at the Fraunhofer Institute for Laser Technology ILT and Tesat-Spacecom have jointly developed the know-how for space-qualified laser components. For the Sentinel mission the diode laser pump module of the Laser Communication Terminal LCT was planned and constructed in Aachen in cooperation with the manufacturer of the LCT, Tesat-Spacecom, and the Ferdinand Braun Institute.

After eight years of preparation, in the early morning of June 23 the time had come: in Kourou in French Guiana, the European Space Agency launched the...

Im Focus: Superslippery islands (but then they get stuck)

A simple reversible process that changes friction in the nanoworld

(Nano)islands that slide freely on a sea of copper, but when they become too large (and too dense) they end up getting stuck: that nicely sums up the system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Breaking through a double wall with a sledgehammer

29.06.2015 | Life Sciences

Lean but sated: Molecular Switch for a Healthy Metabolism discovered

29.06.2015 | Life Sciences

Spintronics Advance Brings Wafer-Scale Quantum Devices Closer to Reality

29.06.2015 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>